Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 2Triple Negative Breast Neoplasms 1Mycosis Fungoides 1Lymphomatoid Papulosis 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Lung Neoplasms 1Disease 1

Interventions

mogamulizumab 7Specimen Handling 5Immunoglobulin G 5Disulfides 5Cyclophosphamide 5Biopsy 5pembrolizumab 4fludarabine 4Magnetic Resonance Spectroscopy 4Brentuximab Vedotin 4hypericin 3fludarabine phosphate 3cemiplimab 3Radiotherapy 3Nivolumab 3sodium-iodide symporter 2X-Rays 2Whole-Body Irradiation 2Tacrolimus 2Phototherapy 2Photons 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Busulfan 2talimogene laherparepvec 1ruxolitinib 1romidepsin 1magrolimab 1duvelisib 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Bexarotene × 1 year × Clear all
NCT05296304 2026-02-04

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
20 enrolled
DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡